National atypical mycobacteria survey, 2000

Authors

  • Frank Haverkort Mycobacterium Reference Laboratory, Western Australian Centre for Pathology and Medical Research (PathCentre), Locked Bag 2009, Nedlands WA 6909

DOI:

https://doi.org/10.33321/cdi.2003.27.42

Keywords:

atypical mycobacteria, nontuberculous mycobacteria, atypical mycobacteriosis, laboratory diagnosis, Mycobacterium

Abstract

Infections with atypical mycobacteria in Australia during 2000 occurred at a rate of 1.8 cases per 100,000 population. The main sites of disease were the respiratory tract, soft tissue, and the lymphatics. The Mycobacterium avium complex was the most common group of mycobacteria isolated from respiratory, lymphatic sites, and blood. The rapidly growing mycobacteria, predominantly the M. fortuitum-M. abscessus-M. chelonae group were the most common soft tissue infections. Atypical mycobacteria were isolated from significant numbers of sputum 'smear positive' patients, requiring further tests to exclude M. tuberculosis. Geographical differences were observed for some Mycobacterium species, notably the isolation of M. haemophilum from Western Australia, and M. ulcerans from Victoria and Queensland. Newer molecular techniques, while improving precision and accuracy of identification, raise additional questions about the ecology of the atypical mycobacteria and their role in disease. Commun Dis Intell 2003;27:180-189.

Downloads

Download data is not yet available.

References

Wayne LG, Good RC, Bottger EC, Butler R, Dorsch M, Ezaki T, et al. Semantide- and chemotaxonomy-based analyses of some problematic phenotypic clusters of slowly growing mycobacteria, a cooperative study of the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol 1996;46:280-297.

Roth A, Reischl U, Schonfeld N, Naumann L, Emler S, Fischer M, et al. Mycobacterium heckeshornense sp. nov. A new pathogenic slowly growing Mycobacterium sp. Causing cavitary lung disease in an immunocompetent patient. J Clin Microbiol 2000 Nov;38:4102-4107.

Lumb R, Bastian I. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2000: Report of the Australian Mycobacterium Laboratory Reference Network. Commun Dis Intell 2002;26:226-233.

Badak FZ, Kiska DL, Setterquist S, Hartley C, O'Connell MA, Hopfer RL. Comparison of mycobacteria growth indicator tube with BACTEC 460 for detection and recovery of mycobacteria from clinical specimens. J Clin Microbiol 1996;34:2236-2239.

Casal M, Gutierrez J, Vaquero M. Comparative evaluation of the mycobacteria growth indicator tube with the BACTEC 460 TB system and Lowenstein-Jensen medium for isolation of mycobacteria from clinical specimens. Int J Tuberc Lung Dis 1997;1:81-84.

Cornfield D B, Beavis KG, Greene JA, Bojak M, Bondi J. Mycobacterial growth and bacterial contamination in the mycobacteria growth indicator tube and BACTEC 460 culture systems. J Clin Microbiol 1997;35:2068-2071.

Pfyffer G E, Welcher HM, Kissling P, Cieslak C, Casal MJ, Gutierrez J, et al. Comparison of the mycobacteria growth indicator tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli. J Clin Microbiol 1997;35:364-368.

Kubica GP, Wayne LG. The mycobacteria: a sourcebook (Part A and B). Marcel Dekker, Inc; 1984

Wayne GW, Sramek HA. Agents of newly recognised or infrequently encountered mycobacterial diseases. Clin Microbiol Rev 1992;5:1-25.

Wallace RJ, et al. Diagnosis and treatment of disease caused by nontuberculosis mycobacteria (Official statement of the American Thoracic Society). Am Rev Respir Dis 1990;142:940-53.

Downloads

Published

30/06/03

How to Cite

Haverkort, Frank. 2003. “National Atypical Mycobacteria Survey, 2000”. Communicable Diseases Intelligence 27 (June):180-89. https://doi.org/10.33321/cdi.2003.27.42.

Issue

Section

Original article

Categories